Theradiag SA (ALTHE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 1.404x

Based on the latest financial reports, Theradiag SA (ALTHE) has a cash flow conversion efficiency ratio of 1.404x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.56 Million ≈ $-4.17 Million USD) by net assets (€-2.54 Million ≈ $-2.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Theradiag SA market capitalisation for the company's overall valuation and market capitalisation.

Theradiag SA - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Theradiag SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Theradiag SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theradiag SA ranked by their cash flow conversion efficiency. See ALTHE debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Gunpoint Exploration Ltd V:GUN	-0.035x
Veru Inc NASDAQ:VERU	-0.166x
Gold Strike Resources Corp. V:GSR	-0.169x
Cyclone Metals Ltd AU:CLE	-0.088x
Canterra Minerals Corporation V:CTM	-0.091x
BluMetric Environmental Inc V:BLM	-0.001x
Farm Price Holdings Berhad KLSE:0304	0.039x
5Th Planet Games A/S OL:5PG	0.004x

Annual Cash Flow Conversion Efficiency for Theradiag SA (2011–2024)

The table below shows the annual cash flow conversion efficiency of Theradiag SA from 2011 to 2024. View Theradiag SA stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-114.00 ≈ $-133.28	€-2.91 Million ≈ $-3.40 Million	25535.088x	+5810417.91%
2023-12-31	€5.65 Million ≈ $6.61 Million	€-2.48 Million ≈ $-2.90 Million	-0.439x	+95.45%
2022-12-31	€544.87K ≈ $637.01K	€-5.27 Million ≈ $-6.16 Million	-9.665x	-416.71%
2021-12-31	€-1.27 Million ≈ $-1.49 Million	€-3.88 Million ≈ $-4.54 Million	3.052x	+197.46%
2020-12-31	€-3.24 Million ≈ $-3.79 Million	€-3.32 Million ≈ $-3.88 Million	1.026x	-97.79%
2019-12-31	€-79.73K ≈ $-93.21K	€-3.69 Million ≈ $-4.32 Million	46.321x	+420.83%
2018-12-31	€-531.93K ≈ $-621.88K	€-4.73 Million ≈ $-5.53 Million	8.894x	+554.82%
2017-12-31	€3.47 Million ≈ $4.06 Million	€-6.79 Million ≈ $-7.93 Million	-1.955x	-37.04%
2016-12-31	€5.58 Million ≈ $6.53 Million	€-7.97 Million ≈ $-9.31 Million	-1.427x	+78.31%
2015-12-31	€756.80K ≈ $884.78K	€-4.98 Million ≈ $-5.82 Million	-6.579x	-252.44%
2014-12-31	€2.77 Million ≈ $3.24 Million	€-5.18 Million ≈ $-6.05 Million	-1.867x	-275.77%
2013-12-31	€-3.80 Million ≈ $-4.45 Million	€-4.04 Million ≈ $-4.72 Million	1.062x	+111.88%
2012-12-31	€297.60K ≈ $347.92K	€-2.66 Million ≈ $-3.11 Million	-8.938x	-13.01%
2011-12-31	€120.37K ≈ $140.73K	€-952.02K ≈ $-1.11 Million	-7.909x	--

About Theradiag SA

PA:ALTHE France Medical Devices

Market Cap

$48.63 Million

€41.59 Million EUR

Market Cap Rank

#23147 Global

#359 in France

Share Price

€0.70

Change (1 day)

-0.56%

52-Week Range

€0.43 - €0.87

All Time High

€8.20